Tate & Lyle has announced the appointment of Vivid Sehgal as the company’s new chief financial officer (CFO), effective 1 May 2021.
Sehgal succeeds Imran Nawaz, who has served as CFO since 2018 when he took over the role from Nick Hampton, who had been appointed as Tate & Lyle CEO. Nawaz will be leaving the company to take up the position of Tesco CFO.
At the beginning of March, Sehgal will join Tate & Lyle as CFO designate and be appointed to the board of directors. Over the following two months, he will work with Nawaz to ensure a smooth transition.
©Tate & Lyle
Previously, Sehgal served as CFO of Delphi Technologies from 2017 to 2020 and prior to that, he was CFO of LivaNova, a medical technology company.
Sehgal has also held senior management positions with Allergan, Gillette and GlaxoSmithKline, working across the US, Europe and the Middle East.
“I am delighted to welcome Vivid to Tate & Lyle and the executive team,” said Tate & Lyle chief executive, Nick Hampton.
“He brings with him a proven track record of financial leadership as well as extensive commercial and transactional experience. I very much look forward to working with him as we continue to progress Tate & Lyle’s growth agenda.”
Tate & Lyle chairman, Gerry Murphy, added: “Vivid’s broad financial, business and international experience will be of great value to Tate & Lyle and he is a very welcome addition to our board.”
© FoodBev Media Ltd 2020
World Dairy Innovation Awards – OPEN FOR EARLY BIRD ENTRIES!
The awards celebrate excellence and innovation across the global dairy industry. Don’t miss out on having your innovations recognised on a global scale.
Early bird deadline 19 March – enter now!
Your privacy We use small files known as ‘cookies’ to enhance your experience of the FoodBev website and analyse site-traffic. Read about how we use cookies or how you may control them in our updated privacy policy and cookie policy. If you continue to use this site, you consent to our use of cookies. Click the ‘OKAY‘ button at the top right of this panel to accept or click here for more information.